Preview

Journal of oncology: diagnostic radiology and radiotherapy

Advanced search

Clinical Observation: Assessment of Factors Associated with the Refusal or Termination of Treatment in Patients with Breast Cancer

https://doi.org/10.37174/2587-7593-2023-6-1-80-87

Abstract

The  study  analyzed  the  clinical  observation of the  psychological characteristics  of a woman  diagnosed with  breast cancer,  who refused  part  of the proposed therapy, and had no contraindications to start  special treatment.

Patient Yu.F., born in 1953, diagnosis: cancer  of the right  breast T1NxM0 ЭР(95 %), ПР(15 %), Her2neu(0), Ki67 (5 %), refused  for personal reasons from the surgical treatment proposed at the 1st stage  (a written refusal was taken), in connection with which  a course  of hormone therapy was prescribed, a course  of remote radiation therapy according to a radical program. When assessing the psychological profile of the patient, the data obtained demonstrate the presence of paradoxical hyperprotection in the patient who refused part of the treatment. Her psychological profile is similar to the psychological characteristics of women with breast cancer, whose course  of the disease ended  in death.  In a study conducted in 2021, data were obtained on women with  a negative outcome of the  disease (death), who were convinced of their  own luck and in the  ability  to control what was happening, used a wide range  of coping  strategies, were more resilient, are optimistic and had a pronounced internality in comparison with women  in whom the disease went into stable  remission.

About the Authors

A. I. Kuznetsova
South Ural State Medical University; National Research Tomsk State University
Russian Federation

64, Vorovsky Str., Chelyabinsk, 454092; 36, Lenin Ave., Tomsk, 634050


Competing Interests:

Not declared



Ya. N. Pakhomova
National Research Tomsk State University; Chelyabinsk State University
Russian Federation

36, Lenin Ave., Tomsk, 634050; 129, Kashirin Brothers Str., Chelyabinsk, 454001


Competing Interests:

Not declared



D. A. Tsiring
National Research Tomsk State University; Ural Branch of the Financial University under the Government of the Russian Federation
Russian Federation

36, Lenin Ave., Tomsk, 634050; 58, Rabotnits Str., Chelyabinsk, 454084


Competing Interests:

Not declared



A. V. Vazhenin
South Ural State Medical University
Russian Federation

64, Vorovsky Str., Chelyabinsk, 454092


Competing Interests:

Not declared



I. V. Ponomareva
National Research Tomsk State University; Ural Branch of the Financial University under the Government of the Russian Federation; Chelyabinsk State University
Russian Federation

36, Lenin Ave., Tomsk, 634050; 58, Rabotnits Str., Chelyabinsk, 454084; 129, Kashirin Brothers Str., Chelyabinsk, 454001


Competing Interests:

Not declared



M. N. Mironchenko
South Ural State Medical University; National Research Tomsk State University
Russian Federation

64, Vorovsky Str., Chelyabinsk, 454092; 36, Lenin Ave., Tomsk, 634050


Competing Interests:

Not declared



M. A. Demchuk
National Research Tomsk State University; Ural Branch of the Financial University under the Government of the Russian Federation; Chelyabinsk State University
Russian Federation

36, Lenin Ave., Tomsk, 634050; 58, Rabotnits Str., Chelyabinsk, 454084; 129, Kashirin Brothers Str., Chelyabinsk, 454001


Competing Interests:

Not declared



Yu. O. Gladkov
National Research Tomsk State University; Ural Branch of the Financial University under the Government of the Russian Federation; Chelyabinsk State University
Russian Federation

36, Lenin Ave., Tomsk, 634050; 58, Rabotnits Str., Chelyabinsk, 454084; 129, Kashirin Brothers Str., Chelyabinsk, 454001


Competing Interests:

Not declared



T. S. Novikova
South Ural State Medical University
Russian Federation

64, Vorovsky Str., Chelyabinsk, 454092


Competing Interests:

Not declared



References

1. Clinical Recommendations. Breast Cancer (Approved by the Scientific and Practical Council of the Ministry of Health of the Russian Federation). 2021. 127 p. (In Russian).

2. Meyer F, Fortin A, Wang CS, et al. Predictors of severe acute and late toxicities in patients with localized head-and-neck cancer treated with radiation therapy. Int J Radiat Oncol Biol Phys. 2012 Mar 15;82(4):1454-62. DOI: 10.1016/j.ijrobp.2011.04.022.

3. Na Suh W, Kong KA, Han Y, et al. Risk factors associated with treatment refusal in lung cancer. Thorac Cancer. 2017;8:443-50. DOI: 10.1111/1759-7714.12461.

4. Chen S.J, Kung P.-T, Huang K.H, et al. Characteristics of the delayed or refusal therapy in breast cancer patients: A longitudinal population-based study in Taiwan. PLoS ONE. 2015;10:e0131305. DOI: 10.1371/journal.pone.0131305.

5. Chiang TY, Wang CH, Lin YF, et al. Colorectal cancer in Taiwan: A case-control retrospective analysis of the impact of a case management program on refusal and discontinuation of treatment. J Adv Nurs. 2018;74:395-406. DOI: 10.1111/jan.13443.

6. Mehta RS, Lenzner D, Argiris A. Race and health disparities in patient refusal of surgery for early-stage non-small cell lung cancer: A SEER cohort study. Ann Surg Oncol. 2011;19:722-7. DOI: 10.1245/s10434-011-2087-3.

7. Dispinzieri M, La Rocca E, Meneghini E, et al. Discontinuation of hormone therapy for elderly breast cancer patients after hypofractionated whole-breast radiotherapy. Med Oncol. 2018;35:107. DOI: 10.1007/s12032-018-1165-9.

8. Eichler M, Singer S, Janni W, et al. Pretreatment quality of life, performance status and their relation to treatment discontinuation and treatment changes in high-risk breast cancer patients receiving chemotherapy: Results from the prospective randomized ADEBAR trial. Breast Cancer. 2016;24:319-25. DOI: 10.1007/s12282-016-0706-3.

9. Freedman RA, Fedewa SA, Punglia RS, et al. Factors associated with radiation therapy incompletion for patients with early-stage breast cancer. Breast Cancer Res Treat. 2015;155:187-99. DOI: 10.1007/s10549-015-3660-4.

10. Honecker F, Wedding U, Kallischnigg G, et al. Risk factors for unplanned discontinuation of scheduled treatment in elderly patients with castration-resistant prostate cancer: Results of the IBuTu study. J Cancer Res Clin Oncol. 2018;144:571-7. DOI: 10.1007/s00432-017-2577-1.

11. Sethi RA, Stamell EF, Price L, et al. Head and neck radiotherapy compliance in an underserved patient population. Laryngoscope. 2010;120:1336-41. DOI: 10.1002/lary.20963.

12. World Health Organization. International Statistical Classification of Diseases and Related Health Problems. 10th Revision ed. 2010. [(accessed on 6 November 2020)]. URL: https://www.who.int/classifications/icd/ICD10Volume2_en_2010.

13. Tsiring DA, Sergeenko EA, Ponomareva IV, et al. Psychological Predictors of Early Access for a Doctor among Women with Primary Luminal Breast Cancer. Siberian Journal of Psychology. 2022;(84):126-42. (In Russian). DOI: 10.17223/17267080/84/7.


Review

For citations:


Kuznetsova A.I., Pakhomova Ya.N., Tsiring D.A., Vazhenin A.V., Ponomareva I.V., Mironchenko M.N., Demchuk M.A., Gladkov Yu.O., Novikova T.S. Clinical Observation: Assessment of Factors Associated with the Refusal or Termination of Treatment in Patients with Breast Cancer. Journal of oncology: diagnostic radiology and radiotherapy. 2023;6(1):80-87. (In Russ.) https://doi.org/10.37174/2587-7593-2023-6-1-80-87

Views: 295


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2587-7593 (Print)
ISSN 2713-167X (Online)